Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroinflammation and Cognitive Impairment in Ovarian Cancer
NCT04542603Phase 1Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Jun 2025
- Primary completion
- Aug 2026
01
Overview
Phase 1, open-label, single-arm trial, sponsored by University of Alabama at Birmingham. Primary endpoint: Concentration and regional distribution of activated brain microglia/macrophages. Planned start Jun 2025; status: withdrawn.
Beyond the preview
Go deeper on NCT04542603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04542603.